The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin versus placebo in hormone receptor–positive early-stage breast cancer (CCTG MA32).
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Bingshu E. Chen
No Relationships to Disclose
 
Wendy R. Parulekar
No Relationships to Disclose
 
Julie Lemieux
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis; Pfizer
Research Funding - Imagia
Patents, Royalties, Other Intellectual Property - Patent related to health. (I)
 
Jennifer A. Ligibel
No Relationships to Disclose
 
Karen A. Gelmon
Honoraria - AstraZeneca; Merck Sharp & Dohme; Novartis Canada Pharmaceuticals Inc; Seagen
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Bristol-Myers Squibb; Genomic Health; Gilead Sciences; Janssen Oncology; Lilly; Merck; Mylan; NanoString Technologies; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Roche (Inst)
Expert Testimony - Genentech
 
Timothy Joseph Whelan
Research Funding - Exact Sciences (Inst)
 
Pamela Jean Goodwin
Research Funding - Epic Sciences (Inst)